Sorry, you need to enable JavaScript to visit this website.
Skip to main content


Rivaroxaban

Therapeutic Category
Anti-Coagulant
API Technology
Synthetic
Dose From
Oral Solids
Dr Reddy's Development Status
Available
Available Regulatory Filing
USA
Canada
Europe
China
Australia
Philippines
Turkey
Argentina
Thailand
Indonesia
Rivaroxaban
Innovator Brand (USA)
XARELTO

We are here to help, if you have any country specific requirements - please Contact Us.